Practice Guidelines & clinical pathway on management of Dyspepsia

21

description

Practice Guidelines & clinical pathway on management of Dyspepsia. Clinical Scenario. 30 year old, male Call center representative Epigastric pain Denies any alarm features Smoker; alcohol and coffee drinker Unremarkable past medical & family history Direct epigastric tenderness. - PowerPoint PPT Presentation

Transcript of Practice Guidelines & clinical pathway on management of Dyspepsia

Page 1: Practice Guidelines & clinical pathway on management of Dyspepsia
Page 2: Practice Guidelines & clinical pathway on management of Dyspepsia

Clinical Scenario

30 year old, male Call center representative Epigastric pain Denies any alarm features Smoker; alcohol and coffee

drinker Unremarkable past medical &

family history Direct epigastric tenderness

Page 3: Practice Guidelines & clinical pathway on management of Dyspepsia

Dyspepsia

Presence of 1 or more of the following symptoms (Rome III Committee):

Postprandial fullness Early satiety Epigastric pain or burning

Page 4: Practice Guidelines & clinical pathway on management of Dyspepsia

Assessment & Diagnosis

Based on history and physical and exam

Consider or rule out: Dietary indiscretion Medication induced Cardiac disease Gastroparesis Hepatobiliary disorders Other systemic disease

Page 5: Practice Guidelines & clinical pathway on management of Dyspepsia

4 Major Causes:

Chronic peptic ulcer disease Gastroesophageal reflux (+/-

esophagitis) Functional dyspepsia (NUD) Malignancy

Page 6: Practice Guidelines & clinical pathway on management of Dyspepsia

Stratify Patients

Age (55 or less/ above 55) Presence of alarm features

Family history of upper GI cancer Unintended weight loss GI bleeding, unexplained anemia Progressive dyspepsia, odynophagia Persistent vomiting Palpable mass or lymphadenopathy Jaundice

Page 7: Practice Guidelines & clinical pathway on management of Dyspepsia

Review of Current Literatures

Peptic ulcer is found in ~5-15% of patients

Gastric or esophageal Adenocarcinoma is identified in <2% of all patients who undergo endoscopy for dyspepsia

Upper gastrointestinal malignancy becomes more common after age 55 years

Page 8: Practice Guidelines & clinical pathway on management of Dyspepsia

Review of Current Literatures

Absence of alarm features has a negative predictive value of >97%

Chronic infection with H. pylori is associated with >80% of peptic ulcers and >1/2 of gastric cancers

Page 9: Practice Guidelines & clinical pathway on management of Dyspepsia

Patient Profile

30 year old, male Burning epigastric pain No alarm symptoms

Page 10: Practice Guidelines & clinical pathway on management of Dyspepsia

Empiric PPI Therapy

Empiric therapy with proton pump inhibitors for 4- 6weeks

Reassurance No further investigations if

symptoms improve Out patient clinic follow-up

Page 11: Practice Guidelines & clinical pathway on management of Dyspepsia

Failed Empirical Therapy

No response to therapy after 7-10 days

Symptoms has not resolved after 6-8 weeks

EGD with biopsy for H. pylori Organic disease (PUD, GERD, CA) Treat accordingly

Page 12: Practice Guidelines & clinical pathway on management of Dyspepsia

Normal EGD (Functional Dyspepsia)

Reassurance Lifestyle changes Treat H. pylori if present

H. pylori regimen: PPI 40 mg 2x a day Amoxicillin 1G 2x a

day Clarithromycin 500mg 2x a day

(10-14 days)

Page 13: Practice Guidelines & clinical pathway on management of Dyspepsia

<55 y/o and below, no alarm

features

Empiric PPI therapy

Response Failed empirical therapy

EGD with biopsy for H.

pylori

Functional dyspepsia

ReassuranceLifestyle modificationsTreat H. pylori if (+)

Organic disease

(PUD, GERD, CA)

>55 y/o or<55 y/o w/ alarm features

Treat accordingly

Page 14: Practice Guidelines & clinical pathway on management of Dyspepsia

H. Pylori Follow -up

Patients who remain symptomatic after initial course of treatment should be retested 4 weeks after completion of the course

Urea breath test or stool antigen test

Some success in using previous triple therapy

Switch to another regimen: PPI+metronidazole+bismuth+tetracycline

Page 15: Practice Guidelines & clinical pathway on management of Dyspepsia

Unresponsive Functional Dyspepsia

Persistent dyspeptic symptoms Not infected with H. pylori or have

been rendered free of H. pylori Do not respond to short course of PPI

therapy (-) negative findings on endoscopy

Page 16: Practice Guidelines & clinical pathway on management of Dyspepsia

Unresponsive Functional Dyspepsia

Reevaluate diagnosis Consider: gastroparesis, biliary or

pancreatic diseases, IBS, anxiety disorder

Limited data on use of antidepressants, prokinetic agents

Page 17: Practice Guidelines & clinical pathway on management of Dyspepsia

References

Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association Technical Review: Evaluation of Dyspepsia. Gasteroenterology 2005, 129:1756-1780.  

American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia Gastroenterology 2005, 129:1753-1755. 

Lam SK, Talley NJ: Report for the 1997 Asia Pacific. Consensus Guidelines on the management of H. pylori. Journal Gasteroenterology & Hepatology 1998, 13:1-2.  

American Society for Gastrointestinal Endoscopy’s The role of endoscopy in dyspepsia. Gastrointestinal Endoscopy 2007, 6:1071-1075

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 8th Edition

Page 18: Practice Guidelines & clinical pathway on management of Dyspepsia
Page 19: Practice Guidelines & clinical pathway on management of Dyspepsia

Test-and-Treat Approach

Test for H. pylori (Urea Breath Test or Stool Antigen Test)

Treat if (+) Trial of PPI therapy if (-)

Do endoscopy if no symptom improvement

Page 20: Practice Guidelines & clinical pathway on management of Dyspepsia

Need for in-patient work-up and care

Severity of dyspepsia Alarm symptoms present Need for additional lab tests and

imaging studies

Page 21: Practice Guidelines & clinical pathway on management of Dyspepsia

Possible Scenario

50 year old with CAD on ASA Severe epigastric pain, weakness, melena Pale

Will need: Hospital admission for medical

management Early endosocopy, CBC Blood transfusion